FDA OKs Novartis' radiotherapy Lutathera for certain neuroendocrine tumors [Seeking Alpha]
ADVANCED ACCELERATOR APPLICATIONS SA AMERICAN DE (AAAP)
Last advanced accelerator applications sa american de earnings: 8/31 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
adacap.com/investor-relations
Company Research
Source: Seeking Alpha
FDA OKs Novartis' radiotherapy Lutathera for certain neuroendocrine tumorsThe FDAapproves Novartis (NVS+0.1%) unit Advanced Accelerator Applications S.A.'s LUTATHERA (lutetium Lu 177) for the treatment of somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs), including foregut, midgut and hindgut neuroendocrine tumors in adult patients, an Orphan Drug indication.LUTATHERA, a targeted therapy that carries a radioactive component, is the first drug of its kind approved in the U.S.Novartiscompleted its $3.9B acquisition of Advanced Accelerator on January 22.Previously:Novartis scoops up Advanced Accelerator (Oct. 30, 2017)Click to subscribe to real-time analytics on NVSNow read:Novartis: Future Looks Bright, But Valuation Is Full »
Show less
Read more
Impact Snapshot
Event Time:
AAAP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AAAP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AAAP alerts
High impacting ADVANCED ACCELERATOR APPLICATIONS SA AMERICAN DE news events
Weekly update
A roundup of the hottest topics